Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Twist Bioscience Corporation
TWST | US
42.07
USD-2.73
-6.09%
TWST | US
Loading StockChartView...
About Twist Bioscience Corporation
Sector
Healthcare
Industry
Diagnostics & Research
Earnings date
30/06/2024
As of date
20/03/2026
Close
42.07
Open
44.60
High
44.68
Low
41.52
Twist Bioscience Corporation a synthetic biology company manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products including synthetic genes tools for sample preparation antibody libraries for drug discovery and development and DNA as a digital data storage medium. The company has collaboration agreements with Victorian Clinical Genetic Services; Vivlion GmbH.; Kyowa Kirin Pharmaceutical Research Inc.; deepCDR Biologics AG; and Centogene N.V to develop advanced sequencing tools. It also has a research collaboration with Boehringer Ingelheim International GmbH to use proprietary antibody libraries to discover therapeutic antibodies against multiple targets. The company was incorporated in 2013 and is headquartered in South San Francisco California.
View LessTWST | US
Risk
64.5
Sharpe
-0.06
Luna's Score
39/100
Recommendation
Sell
Luna says (TWST | US)
What's Working
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Revenue Growth (> 10%)
What's not Working
Negative Momentum (Declining Price)
Weakness based on declining price with high volume
Price Below SMA10D
High Short-term Volatility
High 6-Month Volatility (>65%)
Midcap (2B - 10B USD)
High Market Beta (> 0.8)
High Short percentage (> 15%)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
76.9%1 month
64.5%3 months
67.0%6 months
67.9%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
5.60
Debt to equity
0.18
Debt to assets
0.14
Ent. to EBITDA
-35.26
Ent. to rev.
8.63
PEG
-
Other Fundamentals
EBITDA
-156.67M
MarketCap
2.46B
MarketCap(USD)
2.46B
Div. yield
-
Op. margin
-54.00
Erngs. growth
-
Rev. growth
27.80
Ret. on equity
-38.36
Short ratio
10.73
Short perc.
19.40
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
7.48
Range1M
16.36
Range3M
26.88
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
1.26
Price X volume
56.33M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -35.26 | 12.67 | Cheaper |
| Ent. to Revenue | 8.63 | 44.00 | Cheaper |
| PE Ratio | - | 40.09 | - |
| Price to Book | 5.60 | 77.50 | Cheaper |
| Dividend Yield | - | 1.18 | - |
| Std. Deviation (3M) | 67.03 | 59.59 | Par |
| Debt to Equity | 0.18 | -14.36 | Expensive |
| Debt to Assets | 0.14 | 0.34 | Cheaper |
| Market Cap | 2.46B | 13.71B | Emerging |
